BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32723468)

  • 1. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 2. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of COVID-19: old tricks for new challenges.
    Cunningham AC; Goh HP; Koh D
    Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
    [No Abstract]   [Full Text] [Related]  

  • 4. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
    Rasheed AM; Fatak DF; Hashim HA; Maulood MF; Kabah KK; Almusawi YA; Abdulamir AS
    Infez Med; 2020 Sep; 28(3):357-366. PubMed ID: 32920571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 8. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
    Prajapati S
    Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
    [No Abstract]   [Full Text] [Related]  

  • 9. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive antibody therapy in COVID-19.
    Abraham J
    Nat Rev Immunol; 2020 Jul; 20(7):401-403. PubMed ID: 32533109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
    Tamburello A; Marando M
    Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
    Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Routy JP; Chen Y
    Front Immunol; 2020; 11():570063. PubMed ID: 33072111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 convalescent plasma: phase 2.
    Knudson CM; Jackson JB
    Transfusion; 2020 Jun; 60(6):1332-1333. PubMed ID: 32374890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 17. Convalescent serum lines up as first-choice treatment for coronavirus.
    Sheridan C
    Nat Biotechnol; 2020 Jun; 38(6):655-658. PubMed ID: 32358594
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
    Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D
    Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.